Domača stran1MRK • BIT
add
Merck KGaA
Prejšnji trg. dan.
139,45 €
Letni razpon
128,00 € - 176,30 €
Tržna kapitalizacija
60,87 mrd. EUR
Povprečni obseg
85,00
Razm. P/E
22,75
Dividendna donosnost
1,56 %
Primarna borza
ETR
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
(EUR) | sep. 2024info | Sprememba L/L |
---|---|---|
Prihodek | 5,27 mrd. | 1,80 % |
Stroški poslovanja | 2,05 mrd. | 0,99 % |
Čisti dohodek | 809,00 mio. | 9,47 % |
Čista dobičkovnost prihodkov | 15,36 | 7,49 % |
Earnings per share | 0,49 | −76,49 % |
EBITDA | 1,55 mrd. | 8,95 % |
Efektivna davčna stopnja | 22,15 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
(EUR) | sep. 2024info | Sprememba L/L |
---|---|---|
Denar. in kratkor. naložbe | 3,86 mrd. | 49,44 % |
Skupna sredstva | 50,14 mrd. | 0,47 % |
Skupne obveznosti | 21,75 mrd. | 0,64 % |
Celoten lastniški kapital | 28,39 mrd. | — |
Shares outstanding | 434,95 mio. | — |
Razmerje P/B | 2,14 | — |
Donosnost sredstev | 5,48 % | — |
Donosnost kapitala | 6,93 % | — |
Denarni tok
Neto sprememba denarnih sredstev
(EUR) | sep. 2024info | Sprememba L/L |
---|---|---|
Čisti dohodek | 809,00 mio. | 9,47 % |
Denar iz dejavnosti | 1,46 mrd. | 16,18 % |
Denar iz naložb | −1,70 mrd. | −385,14 % |
Denar iz financiranja | 727,00 mio. | 340,73 % |
Neto sprememba denarnih sredstev | 476,00 mio. | −21,19 % |
Prost denarni tok | 640,00 mio. | −16,07 % |
Vizitka
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally.
Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing, as well as other Research and Development units in Taiwan, France, Israel, South Korea, India, and the UK. Merck pioneered the commercial manufacture of morphine in the 19th century and for a time held a virtual monopoly on cocaine.
Merck was privately owned until going public on the Frankfurt Stock Exchange in 1995 and is listed on the DAX index of Germany's top companies. The Merck family still controls a majority of 70.3% of the company's shares. Wikipedia
Generalni direktor
Datum ustanovitve
26. avg. 1668
Spletno mesto
Zaposleni
62.255